Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADIPOA-2: Autologous Adipose Derived Mesenchymal Stromal Cells for Knee Osteoarthritis
NCT02838069Phase 2Completed
- Sponsor
- CHU Montpellier
- Start
- Sep 2016
- Primary completion
- Sep 2022
- Countries
- 1
01
Overview
A Phase 2 trial of autologous adipose-derived mesenchymal stromal cells in osteoarthritis (OA), sponsored by CHU Montpellier. Started Sep 2016; status: completed.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02838069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02838069.